Infectious Disease Clinics of North America volume 27, issue 2, P359-377 2013 DOI: 10.1016/j.idc.2013.02.012 View full text
|
|
Share
Joseph G. Timpone, Raffaele Girlanda, Lauren Rudolph, Thomas M. Fishbein

Abstract: Intestinal and multivisceral transplantation has become an effective treatment option for patients with intestinal failure. More potent immunosuppressive therapy has resulted in a decreased incidence of acute rejection and has improved patient survival. However, infectious complications can cause significant morbidity both before and after transplantation. In comparison with other solid organ transplant recipients, these patients experience higher rates of acute allograft rejection, thus requiring higher level…

expand abstract